Global Lung Cancer Diagnostic Tests Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Lung Cancer Diagnostic Tests market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Diagnostic Tests Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Diagnostic Tests market in any manner.
Global Lung Cancer Diagnostic Tests Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US
Market Segmentation (by Type)
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Market Segmentation (by Application)
Precision Medicine
Personalized Medicine
Cancer Monitoring
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostic Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Lung Cancer Diagnostic Tests market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Diagnostic Tests Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Diagnostic Tests market in any manner.
Global Lung Cancer Diagnostic Tests Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US
Market Segmentation (by Type)
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Market Segmentation (by Application)
Precision Medicine
Personalized Medicine
Cancer Monitoring
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Lung Cancer Diagnostic Tests Market
- Overview of the regional outlook of the Lung Cancer Diagnostic Tests Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostic Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic Tests Segment by Type
1.2.2 Lung Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTIC TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lung Cancer Diagnostic Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTIC TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Diagnostic Tests Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Diagnostic Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Diagnostic Tests Sales Sites, Area Served, Product Type
3.6 Lung Cancer Diagnostic Tests Market Competitive Situation and Trends
3.6.1 Lung Cancer Diagnostic Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Diagnostic Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTIC TESTS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTIC TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic Tests Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Diagnostic Tests Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Diagnostic Tests Price by Type (2019-2024)
7 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic Tests Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Diagnostic Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
8 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Diagnostic Tests Sales by Region
8.1.1 Global Lung Cancer Diagnostic Tests Sales by Region
8.1.2 Global Lung Cancer Diagnostic Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostic Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostic Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostic Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostic Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostic Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Advpharma Inc
9.1.1 Advpharma Inc Lung Cancer Diagnostic Tests Basic Information
9.1.2 Advpharma Inc Lung Cancer Diagnostic Tests Product Overview
9.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Product Market Performance
9.1.4 Advpharma Inc Business Overview
9.1.5 Advpharma Inc Lung Cancer Diagnostic Tests SWOT Analysis
9.1.6 Advpharma Inc Recent Developments
9.2 AIT Austrian Institute of Technology GmbH
9.2.1 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Basic Information
9.2.2 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Overview
9.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Market Performance
9.2.4 AIT Austrian Institute of Technology GmbH Business Overview
9.2.5 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests SWOT Analysis
9.2.6 AIT Austrian Institute of Technology GmbH Recent Developments
9.3 Courtagen Life Sciences Inc
9.3.1 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Basic Information
9.3.2 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Overview
9.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Market Performance
9.3.4 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests SWOT Analysis
9.3.5 Courtagen Life Sciences Inc Business Overview
9.3.6 Courtagen Life Sciences Inc Recent Developments
9.4 DiagnoCure Inc. (Inactive)
9.4.1 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Basic Information
9.4.2 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Overview
9.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Market Performance
9.4.4 DiagnoCure Inc. (Inactive) Business Overview
9.4.5 DiagnoCure Inc. (Inactive) Recent Developments
9.5 BioMark Diagnostics Inc.
9.5.1 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Basic Information
9.5.2 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Overview
9.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Market Performance
9.5.4 BioMark Diagnostics Inc. Business Overview
9.5.5 BioMark Diagnostics Inc. Recent Developments
9.6 BioMarker Strategies LLC
9.6.1 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Basic Information
9.6.2 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Overview
9.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Market Performance
9.6.4 BioMarker Strategies LLC Business Overview
9.6.5 BioMarker Strategies LLC Recent Developments
9.7 Emory University
9.7.1 Emory University Lung Cancer Diagnostic Tests Basic Information
9.7.2 Emory University Lung Cancer Diagnostic Tests Product Overview
9.7.3 Emory University Lung Cancer Diagnostic Tests Product Market Performance
9.7.4 Emory University Business Overview
9.7.5 Emory University Recent Developments
9.8 Epigenomics AG
9.8.1 Epigenomics AG Lung Cancer Diagnostic Tests Basic Information
9.8.2 Epigenomics AG Lung Cancer Diagnostic Tests Product Overview
9.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Product Market Performance
9.8.4 Epigenomics AG Business Overview
9.8.5 Epigenomics AG Recent Developments
9.9 GlycoZym
9.9.1 GlycoZym Lung Cancer Diagnostic Tests Basic Information
9.9.2 GlycoZym Lung Cancer Diagnostic Tests Product Overview
9.9.3 GlycoZym Lung Cancer Diagnostic Tests Product Market Performance
9.9.4 GlycoZym Business Overview
9.9.5 GlycoZym Recent Developments
9.10 HalioDx SAS
9.10.1 HalioDx SAS Lung Cancer Diagnostic Tests Basic Information
9.10.2 HalioDx SAS Lung Cancer Diagnostic Tests Product Overview
9.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Product Market Performance
9.10.4 HalioDx SAS Business Overview
9.10.5 HalioDx SAS Recent Developments
9.11 Louisville Bioscience, Inc.
9.11.1 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Basic Information
9.11.2 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Overview
9.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Market Performance
9.11.4 Louisville Bioscience, Inc. Business Overview
9.11.5 Louisville Bioscience, Inc. Recent Developments
9.12 Mayo Clinic US
9.12.1 Mayo Clinic US Lung Cancer Diagnostic Tests Basic Information
9.12.2 Mayo Clinic US Lung Cancer Diagnostic Tests Product Overview
9.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Product Market Performance
9.12.4 Mayo Clinic US Business Overview
9.12.5 Mayo Clinic US Recent Developments
10 LUNG CANCER DIAGNOSTIC TESTS MARKET FORECAST BY REGION
10.1 Global Lung Cancer Diagnostic Tests Market Size Forecast
10.2 Global Lung Cancer Diagnostic Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Diagnostic Tests Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Diagnostic Tests Market Size Forecast by Region
10.2.4 South America Lung Cancer Diagnostic Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Diagnostic Tests by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Lung Cancer Diagnostic Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lung Cancer Diagnostic Tests by Type (2025-2030)
11.1.2 Global Lung Cancer Diagnostic Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lung Cancer Diagnostic Tests by Type (2025-2030)
11.2 Global Lung Cancer Diagnostic Tests Market Forecast by Application (2025-2030)
11.2.1 Global Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application
11.2.2 Global Lung Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic Tests Segment by Type
1.2.2 Lung Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTIC TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lung Cancer Diagnostic Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTIC TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Diagnostic Tests Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Diagnostic Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Diagnostic Tests Sales Sites, Area Served, Product Type
3.6 Lung Cancer Diagnostic Tests Market Competitive Situation and Trends
3.6.1 Lung Cancer Diagnostic Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Diagnostic Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTIC TESTS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTIC TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic Tests Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Diagnostic Tests Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Diagnostic Tests Price by Type (2019-2024)
7 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic Tests Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Diagnostic Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
8 LUNG CANCER DIAGNOSTIC TESTS MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Diagnostic Tests Sales by Region
8.1.1 Global Lung Cancer Diagnostic Tests Sales by Region
8.1.2 Global Lung Cancer Diagnostic Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostic Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostic Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostic Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostic Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostic Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Advpharma Inc
9.1.1 Advpharma Inc Lung Cancer Diagnostic Tests Basic Information
9.1.2 Advpharma Inc Lung Cancer Diagnostic Tests Product Overview
9.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Product Market Performance
9.1.4 Advpharma Inc Business Overview
9.1.5 Advpharma Inc Lung Cancer Diagnostic Tests SWOT Analysis
9.1.6 Advpharma Inc Recent Developments
9.2 AIT Austrian Institute of Technology GmbH
9.2.1 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Basic Information
9.2.2 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Overview
9.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Market Performance
9.2.4 AIT Austrian Institute of Technology GmbH Business Overview
9.2.5 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests SWOT Analysis
9.2.6 AIT Austrian Institute of Technology GmbH Recent Developments
9.3 Courtagen Life Sciences Inc
9.3.1 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Basic Information
9.3.2 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Overview
9.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Market Performance
9.3.4 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests SWOT Analysis
9.3.5 Courtagen Life Sciences Inc Business Overview
9.3.6 Courtagen Life Sciences Inc Recent Developments
9.4 DiagnoCure Inc. (Inactive)
9.4.1 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Basic Information
9.4.2 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Overview
9.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Market Performance
9.4.4 DiagnoCure Inc. (Inactive) Business Overview
9.4.5 DiagnoCure Inc. (Inactive) Recent Developments
9.5 BioMark Diagnostics Inc.
9.5.1 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Basic Information
9.5.2 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Overview
9.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Market Performance
9.5.4 BioMark Diagnostics Inc. Business Overview
9.5.5 BioMark Diagnostics Inc. Recent Developments
9.6 BioMarker Strategies LLC
9.6.1 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Basic Information
9.6.2 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Overview
9.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Market Performance
9.6.4 BioMarker Strategies LLC Business Overview
9.6.5 BioMarker Strategies LLC Recent Developments
9.7 Emory University
9.7.1 Emory University Lung Cancer Diagnostic Tests Basic Information
9.7.2 Emory University Lung Cancer Diagnostic Tests Product Overview
9.7.3 Emory University Lung Cancer Diagnostic Tests Product Market Performance
9.7.4 Emory University Business Overview
9.7.5 Emory University Recent Developments
9.8 Epigenomics AG
9.8.1 Epigenomics AG Lung Cancer Diagnostic Tests Basic Information
9.8.2 Epigenomics AG Lung Cancer Diagnostic Tests Product Overview
9.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Product Market Performance
9.8.4 Epigenomics AG Business Overview
9.8.5 Epigenomics AG Recent Developments
9.9 GlycoZym
9.9.1 GlycoZym Lung Cancer Diagnostic Tests Basic Information
9.9.2 GlycoZym Lung Cancer Diagnostic Tests Product Overview
9.9.3 GlycoZym Lung Cancer Diagnostic Tests Product Market Performance
9.9.4 GlycoZym Business Overview
9.9.5 GlycoZym Recent Developments
9.10 HalioDx SAS
9.10.1 HalioDx SAS Lung Cancer Diagnostic Tests Basic Information
9.10.2 HalioDx SAS Lung Cancer Diagnostic Tests Product Overview
9.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Product Market Performance
9.10.4 HalioDx SAS Business Overview
9.10.5 HalioDx SAS Recent Developments
9.11 Louisville Bioscience, Inc.
9.11.1 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Basic Information
9.11.2 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Overview
9.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Market Performance
9.11.4 Louisville Bioscience, Inc. Business Overview
9.11.5 Louisville Bioscience, Inc. Recent Developments
9.12 Mayo Clinic US
9.12.1 Mayo Clinic US Lung Cancer Diagnostic Tests Basic Information
9.12.2 Mayo Clinic US Lung Cancer Diagnostic Tests Product Overview
9.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Product Market Performance
9.12.4 Mayo Clinic US Business Overview
9.12.5 Mayo Clinic US Recent Developments
10 LUNG CANCER DIAGNOSTIC TESTS MARKET FORECAST BY REGION
10.1 Global Lung Cancer Diagnostic Tests Market Size Forecast
10.2 Global Lung Cancer Diagnostic Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Diagnostic Tests Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Diagnostic Tests Market Size Forecast by Region
10.2.4 South America Lung Cancer Diagnostic Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Diagnostic Tests by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Lung Cancer Diagnostic Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lung Cancer Diagnostic Tests by Type (2025-2030)
11.1.2 Global Lung Cancer Diagnostic Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lung Cancer Diagnostic Tests by Type (2025-2030)
11.2 Global Lung Cancer Diagnostic Tests Market Forecast by Application (2025-2030)
11.2.1 Global Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application
11.2.2 Global Lung Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Diagnostic Tests Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Diagnostic Tests Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Diagnostic Tests Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Diagnostic Tests Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lung Cancer Diagnostic Tests Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic Tests as of 2022)
Table 10. Global Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lung Cancer Diagnostic Tests Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Diagnostic Tests Product Type
Table 13. Global Lung Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lung Cancer Diagnostic Tests
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lung Cancer Diagnostic Tests Market Challenges
Table 22. Global Lung Cancer Diagnostic Tests Sales by Type (K Units)
Table 23. Global Lung Cancer Diagnostic Tests Market Size by Type (M USD)
Table 24. Global Lung Cancer Diagnostic Tests Sales (K Units) by Type (2019-2024)
Table 25. Global Lung Cancer Diagnostic Tests Sales Market Share by Type (2019-2024)
Table 26. Global Lung Cancer Diagnostic Tests Market Size (M USD) by Type (2019-2024)
Table 27. Global Lung Cancer Diagnostic Tests Market Size Share by Type (2019-2024)
Table 28. Global Lung Cancer Diagnostic Tests Price (USD/Unit) by Type (2019-2024)
Table 29. Global Lung Cancer Diagnostic Tests Sales (K Units) by Application
Table 30. Global Lung Cancer Diagnostic Tests Market Size by Application
Table 31. Global Lung Cancer Diagnostic Tests Sales by Application (2019-2024) & (K Units)
Table 32. Global Lung Cancer Diagnostic Tests Sales Market Share by Application (2019-2024)
Table 33. Global Lung Cancer Diagnostic Tests Sales by Application (2019-2024) & (M USD)
Table 34. Global Lung Cancer Diagnostic Tests Market Share by Application (2019-2024)
Table 35. Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
Table 36. Global Lung Cancer Diagnostic Tests Sales by Region (2019-2024) & (K Units)
Table 37. Global Lung Cancer Diagnostic Tests Sales Market Share by Region (2019-2024)
Table 38. North America Lung Cancer Diagnostic Tests Sales by Country (2019-2024) & (K Units)
Table 39. Europe Lung Cancer Diagnostic Tests Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Lung Cancer Diagnostic Tests Sales by Region (2019-2024) & (K Units)
Table 41. South America Lung Cancer Diagnostic Tests Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Lung Cancer Diagnostic Tests Sales by Region (2019-2024) & (K Units)
Table 43. Advpharma Inc Lung Cancer Diagnostic Tests Basic Information
Table 44. Advpharma Inc Lung Cancer Diagnostic Tests Product Overview
Table 45. Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Advpharma Inc Business Overview
Table 47. Advpharma Inc Lung Cancer Diagnostic Tests SWOT Analysis
Table 48. Advpharma Inc Recent Developments
Table 49. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Basic Information
Table 50. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Overview
Table 51. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. AIT Austrian Institute of Technology GmbH Business Overview
Table 53. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests SWOT Analysis
Table 54. AIT Austrian Institute of Technology GmbH Recent Developments
Table 55. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Basic Information
Table 56. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Overview
Table 57. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests SWOT Analysis
Table 59. Courtagen Life Sciences Inc Business Overview
Table 60. Courtagen Life Sciences Inc Recent Developments
Table 61. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Basic Information
Table 62. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Overview
Table 63. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. DiagnoCure Inc. (Inactive) Business Overview
Table 65. DiagnoCure Inc. (Inactive) Recent Developments
Table 66. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Basic Information
Table 67. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Overview
Table 68. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BioMark Diagnostics Inc. Business Overview
Table 70. BioMark Diagnostics Inc. Recent Developments
Table 71. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Basic Information
Table 72. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Overview
Table 73. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BioMarker Strategies LLC Business Overview
Table 75. BioMarker Strategies LLC Recent Developments
Table 76. Emory University Lung Cancer Diagnostic Tests Basic Information
Table 77. Emory University Lung Cancer Diagnostic Tests Product Overview
Table 78. Emory University Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Emory University Business Overview
Table 80. Emory University Recent Developments
Table 81. Epigenomics AG Lung Cancer Diagnostic Tests Basic Information
Table 82. Epigenomics AG Lung Cancer Diagnostic Tests Product Overview
Table 83. Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Epigenomics AG Business Overview
Table 85. Epigenomics AG Recent Developments
Table 86. GlycoZym Lung Cancer Diagnostic Tests Basic Information
Table 87. GlycoZym Lung Cancer Diagnostic Tests Product Overview
Table 88. GlycoZym Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GlycoZym Business Overview
Table 90. GlycoZym Recent Developments
Table 91. HalioDx SAS Lung Cancer Diagnostic Tests Basic Information
Table 92. HalioDx SAS Lung Cancer Diagnostic Tests Product Overview
Table 93. HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. HalioDx SAS Business Overview
Table 95. HalioDx SAS Recent Developments
Table 96. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Basic Information
Table 97. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Overview
Table 98. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Louisville Bioscience, Inc. Business Overview
Table 100. Louisville Bioscience, Inc. Recent Developments
Table 101. Mayo Clinic US Lung Cancer Diagnostic Tests Basic Information
Table 102. Mayo Clinic US Lung Cancer Diagnostic Tests Product Overview
Table 103. Mayo Clinic US Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Mayo Clinic US Business Overview
Table 105. Mayo Clinic US Recent Developments
Table 106. Global Lung Cancer Diagnostic Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Lung Cancer Diagnostic Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Lung Cancer Diagnostic Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Lung Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Lung Cancer Diagnostic Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Lung Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Lung Cancer Diagnostic Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Lung Cancer Diagnostic Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Lung Cancer Diagnostic Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Lung Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Lung Cancer Diagnostic Tests Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Lung Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Lung Cancer Diagnostic Tests Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Lung Cancer Diagnostic Tests Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Lung Cancer Diagnostic Tests Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Lung Cancer Diagnostic Tests Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Diagnostic Tests Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Diagnostic Tests Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Diagnostic Tests Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Diagnostic Tests Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lung Cancer Diagnostic Tests Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic Tests as of 2022)
Table 10. Global Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lung Cancer Diagnostic Tests Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Diagnostic Tests Product Type
Table 13. Global Lung Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lung Cancer Diagnostic Tests
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lung Cancer Diagnostic Tests Market Challenges
Table 22. Global Lung Cancer Diagnostic Tests Sales by Type (K Units)
Table 23. Global Lung Cancer Diagnostic Tests Market Size by Type (M USD)
Table 24. Global Lung Cancer Diagnostic Tests Sales (K Units) by Type (2019-2024)
Table 25. Global Lung Cancer Diagnostic Tests Sales Market Share by Type (2019-2024)
Table 26. Global Lung Cancer Diagnostic Tests Market Size (M USD) by Type (2019-2024)
Table 27. Global Lung Cancer Diagnostic Tests Market Size Share by Type (2019-2024)
Table 28. Global Lung Cancer Diagnostic Tests Price (USD/Unit) by Type (2019-2024)
Table 29. Global Lung Cancer Diagnostic Tests Sales (K Units) by Application
Table 30. Global Lung Cancer Diagnostic Tests Market Size by Application
Table 31. Global Lung Cancer Diagnostic Tests Sales by Application (2019-2024) & (K Units)
Table 32. Global Lung Cancer Diagnostic Tests Sales Market Share by Application (2019-2024)
Table 33. Global Lung Cancer Diagnostic Tests Sales by Application (2019-2024) & (M USD)
Table 34. Global Lung Cancer Diagnostic Tests Market Share by Application (2019-2024)
Table 35. Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
Table 36. Global Lung Cancer Diagnostic Tests Sales by Region (2019-2024) & (K Units)
Table 37. Global Lung Cancer Diagnostic Tests Sales Market Share by Region (2019-2024)
Table 38. North America Lung Cancer Diagnostic Tests Sales by Country (2019-2024) & (K Units)
Table 39. Europe Lung Cancer Diagnostic Tests Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Lung Cancer Diagnostic Tests Sales by Region (2019-2024) & (K Units)
Table 41. South America Lung Cancer Diagnostic Tests Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Lung Cancer Diagnostic Tests Sales by Region (2019-2024) & (K Units)
Table 43. Advpharma Inc Lung Cancer Diagnostic Tests Basic Information
Table 44. Advpharma Inc Lung Cancer Diagnostic Tests Product Overview
Table 45. Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Advpharma Inc Business Overview
Table 47. Advpharma Inc Lung Cancer Diagnostic Tests SWOT Analysis
Table 48. Advpharma Inc Recent Developments
Table 49. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Basic Information
Table 50. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Overview
Table 51. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. AIT Austrian Institute of Technology GmbH Business Overview
Table 53. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests SWOT Analysis
Table 54. AIT Austrian Institute of Technology GmbH Recent Developments
Table 55. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Basic Information
Table 56. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Overview
Table 57. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests SWOT Analysis
Table 59. Courtagen Life Sciences Inc Business Overview
Table 60. Courtagen Life Sciences Inc Recent Developments
Table 61. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Basic Information
Table 62. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Overview
Table 63. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. DiagnoCure Inc. (Inactive) Business Overview
Table 65. DiagnoCure Inc. (Inactive) Recent Developments
Table 66. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Basic Information
Table 67. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Overview
Table 68. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BioMark Diagnostics Inc. Business Overview
Table 70. BioMark Diagnostics Inc. Recent Developments
Table 71. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Basic Information
Table 72. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Overview
Table 73. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BioMarker Strategies LLC Business Overview
Table 75. BioMarker Strategies LLC Recent Developments
Table 76. Emory University Lung Cancer Diagnostic Tests Basic Information
Table 77. Emory University Lung Cancer Diagnostic Tests Product Overview
Table 78. Emory University Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Emory University Business Overview
Table 80. Emory University Recent Developments
Table 81. Epigenomics AG Lung Cancer Diagnostic Tests Basic Information
Table 82. Epigenomics AG Lung Cancer Diagnostic Tests Product Overview
Table 83. Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Epigenomics AG Business Overview
Table 85. Epigenomics AG Recent Developments
Table 86. GlycoZym Lung Cancer Diagnostic Tests Basic Information
Table 87. GlycoZym Lung Cancer Diagnostic Tests Product Overview
Table 88. GlycoZym Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GlycoZym Business Overview
Table 90. GlycoZym Recent Developments
Table 91. HalioDx SAS Lung Cancer Diagnostic Tests Basic Information
Table 92. HalioDx SAS Lung Cancer Diagnostic Tests Product Overview
Table 93. HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. HalioDx SAS Business Overview
Table 95. HalioDx SAS Recent Developments
Table 96. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Basic Information
Table 97. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Overview
Table 98. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Louisville Bioscience, Inc. Business Overview
Table 100. Louisville Bioscience, Inc. Recent Developments
Table 101. Mayo Clinic US Lung Cancer Diagnostic Tests Basic Information
Table 102. Mayo Clinic US Lung Cancer Diagnostic Tests Product Overview
Table 103. Mayo Clinic US Lung Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Mayo Clinic US Business Overview
Table 105. Mayo Clinic US Recent Developments
Table 106. Global Lung Cancer Diagnostic Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Lung Cancer Diagnostic Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Lung Cancer Diagnostic Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Lung Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Lung Cancer Diagnostic Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Lung Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Lung Cancer Diagnostic Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Lung Cancer Diagnostic Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Lung Cancer Diagnostic Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Lung Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Lung Cancer Diagnostic Tests Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Lung Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Lung Cancer Diagnostic Tests Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Lung Cancer Diagnostic Tests Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Lung Cancer Diagnostic Tests Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Lung Cancer Diagnostic Tests Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Lung Cancer Diagnostic Tests Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Lung Cancer Diagnostic Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostic Tests Market Size (M USD), 2019-2030
Figure 5. Global Lung Cancer Diagnostic Tests Market Size (M USD) (2019-2030)
Figure 6. Global Lung Cancer Diagnostic Tests Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Diagnostic Tests Market Size by Country (M USD)
Figure 11. Lung Cancer Diagnostic Tests Sales Share by Manufacturers in 2023
Figure 12. Global Lung Cancer Diagnostic Tests Revenue Share by Manufacturers in 2023
Figure 13. Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostic Tests Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lung Cancer Diagnostic Tests Market Share by Type
Figure 18. Sales Market Share of Lung Cancer Diagnostic Tests by Type (2019-2024)
Figure 19. Sales Market Share of Lung Cancer Diagnostic Tests by Type in 2023
Figure 20. Market Size Share of Lung Cancer Diagnostic Tests by Type (2019-2024)
Figure 21. Market Size Market Share of Lung Cancer Diagnostic Tests by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Diagnostic Tests Market Share by Application
Figure 24. Global Lung Cancer Diagnostic Tests Sales Market Share by Application (2019-2024)
Figure 25. Global Lung Cancer Diagnostic Tests Sales Market Share by Application in 2023
Figure 26. Global Lung Cancer Diagnostic Tests Market Share by Application (2019-2024)
Figure 27. Global Lung Cancer Diagnostic Tests Market Share by Application in 2023
Figure 28. Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lung Cancer Diagnostic Tests Sales Market Share by Region (2019-2024)
Figure 30. North America Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Lung Cancer Diagnostic Tests Sales Market Share by Country in 2023
Figure 32. U.S. Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Lung Cancer Diagnostic Tests Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Lung Cancer Diagnostic Tests Sales Market Share by Country in 2023
Figure 37. Germany Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Lung Cancer Diagnostic Tests Sales Market Share by Region in 2023
Figure 44. China Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 50. South America Lung Cancer Diagnostic Tests Sales Market Share by Country in 2023
Figure 51. Brazil Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Lung Cancer Diagnostic Tests Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Lung Cancer Diagnostic Tests Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Lung Cancer Diagnostic Tests Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Lung Cancer Diagnostic Tests Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Lung Cancer Diagnostic Tests Market Share Forecast by Type (2025-2030)
Figure 65. Global Lung Cancer Diagnostic Tests Sales Forecast by Application (2025-2030)
Figure 66. Global Lung Cancer Diagnostic Tests Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Lung Cancer Diagnostic Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostic Tests Market Size (M USD), 2019-2030
Figure 5. Global Lung Cancer Diagnostic Tests Market Size (M USD) (2019-2030)
Figure 6. Global Lung Cancer Diagnostic Tests Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Diagnostic Tests Market Size by Country (M USD)
Figure 11. Lung Cancer Diagnostic Tests Sales Share by Manufacturers in 2023
Figure 12. Global Lung Cancer Diagnostic Tests Revenue Share by Manufacturers in 2023
Figure 13. Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostic Tests Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lung Cancer Diagnostic Tests Market Share by Type
Figure 18. Sales Market Share of Lung Cancer Diagnostic Tests by Type (2019-2024)
Figure 19. Sales Market Share of Lung Cancer Diagnostic Tests by Type in 2023
Figure 20. Market Size Share of Lung Cancer Diagnostic Tests by Type (2019-2024)
Figure 21. Market Size Market Share of Lung Cancer Diagnostic Tests by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Diagnostic Tests Market Share by Application
Figure 24. Global Lung Cancer Diagnostic Tests Sales Market Share by Application (2019-2024)
Figure 25. Global Lung Cancer Diagnostic Tests Sales Market Share by Application in 2023
Figure 26. Global Lung Cancer Diagnostic Tests Market Share by Application (2019-2024)
Figure 27. Global Lung Cancer Diagnostic Tests Market Share by Application in 2023
Figure 28. Global Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lung Cancer Diagnostic Tests Sales Market Share by Region (2019-2024)
Figure 30. North America Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Lung Cancer Diagnostic Tests Sales Market Share by Country in 2023
Figure 32. U.S. Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Lung Cancer Diagnostic Tests Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Lung Cancer Diagnostic Tests Sales Market Share by Country in 2023
Figure 37. Germany Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Lung Cancer Diagnostic Tests Sales Market Share by Region in 2023
Figure 44. China Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 50. South America Lung Cancer Diagnostic Tests Sales Market Share by Country in 2023
Figure 51. Brazil Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Lung Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Lung Cancer Diagnostic Tests Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Lung Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Lung Cancer Diagnostic Tests Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Lung Cancer Diagnostic Tests Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Lung Cancer Diagnostic Tests Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Lung Cancer Diagnostic Tests Market Share Forecast by Type (2025-2030)
Figure 65. Global Lung Cancer Diagnostic Tests Sales Forecast by Application (2025-2030)
Figure 66. Global Lung Cancer Diagnostic Tests Market Share Forecast by Application (2025-2030)
